ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population
Rheumatology and Therapy
◽
10.1007/s40744-018-0118-2
◽
2018
◽
Vol 5
(2)
◽
pp. 383-401
◽
Cited By ~ 4
Author(s):
Stephen Hall
◽
Peter Nash
◽
Maureen Rischmueller
◽
David Bossingham
◽
Paul Bird
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Efficacy And Safety
◽
Janus Kinase Inhibitor
◽
Rheumatoid Arthritis Population
Download Full-text
Related Documents
Cited By
References
THU0228 Tofacitinib, an Oral Janus Kinase Inhibitor: Post-HOC Analyses of Efficacy and Safety of Monotherapy Versus Combination Therapy in a Phase 3 Rheumatoid Arthritis Population
Annals of the Rheumatic Diseases
◽
10.1136/annrheumdis-2013-eular.756
◽
2013
◽
Vol 72
(Suppl 3)
◽
pp. A242.1-A242
Author(s):
E. Keystone
◽
R. Fleischmann
◽
R. van Vollenhoven
◽
J. Kremer
◽
D. Gruben
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Combination Therapy
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Efficacy And Safety
◽
Phase 3
◽
Janus Kinase Inhibitor
◽
Rheumatoid Arthritis Population
◽
Post Hoc
Download Full-text
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Reumatología Clínica (English Edition)
◽
10.1016/j.reumae.2017.04.009
◽
2019
◽
Vol 15
(1)
◽
pp. 43-53
Author(s):
Ruben Burgos-Vargas
◽
Mario Cardiel
◽
Daniel Xibillèc)
◽
Cèc)sar Pacheco-Tena
◽
Virginia Pascual-Ramos
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Efficacy And Safety
◽
Phase 3
◽
Janus Kinase Inhibitor
Download Full-text
Tofacitinib, an oral Janus kinase inhibitor, in patients from Colombia with rheumatoid arthritis: Pooled efficacy and safety analyses of data from phase III studies
Revista Colombiana de Reumatología
◽
10.1016/j.rcreu.2018.08.002
◽
2018
◽
Vol 25
(4)
◽
pp. 233-244
Author(s):
Patricia Vélez
◽
Juan J. Jaller
◽
William J. Otero Escalante
◽
Erika G. García
◽
Ricardo Rojo
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Phase Iii
◽
Efficacy And Safety
◽
Janus Kinase Inhibitor
◽
Phase Iii Studies
Download Full-text
Tofacitinib, an oral Janus kinase inhibitor, in patients from Colombia with rheumatoid arthritis: Pooled efficacy and safety analyses of data from phase III studies
Revista Colombiana de Reumatología (English Edition)
◽
10.1016/j.rcreue.2018.08.002
◽
2018
◽
Vol 25
(4)
◽
pp. 233-244
Author(s):
Patricia Vélez
◽
Juan J. Jaller
◽
William J. Otero Escalante
◽
Erika G. García
◽
Ricardo Rojo
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Phase Iii
◽
Efficacy And Safety
◽
Janus Kinase Inhibitor
◽
Phase Iii Studies
Download Full-text
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Reumatología Clínica
◽
10.1016/j.reuma.2017.04.006
◽
2019
◽
Vol 15
(1)
◽
pp. 43-53
Author(s):
Ruben Burgos-Vargas
◽
Mario Cardiel
◽
Daniel Xibillé
◽
César Pacheco-Tena
◽
Virginia Pascual-Ramos
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Efficacy And Safety
◽
Phase 3
◽
Janus Kinase Inhibitor
Download Full-text
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies
Reumatología Clínica (English Edition)
◽
10.1016/j.reumae.2016.04.015
◽
2017
◽
Vol 13
(4)
◽
pp. 201-209
Author(s):
Sebastião Cezar Radominski
◽
Mario Humberto Cardiel
◽
Gustavo Citera
◽
Annelise Goecke
◽
Juan Jose Jaller
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Latin American
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Efficacy And Safety
◽
Phase 3
◽
Janus Kinase Inhibitor
Download Full-text
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies
Reumatología Clínica
◽
10.1016/j.reuma.2016.04.010
◽
2017
◽
Vol 13
(4)
◽
pp. 201-209
◽
Cited By ~ 3
Author(s):
Sebastião Cezar Radominski
◽
Mario Humberto Cardiel
◽
Gustavo Citera
◽
Annelise Goecke
◽
Juan Jose Jaller
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Latin American
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Efficacy And Safety
◽
Phase 3
◽
Janus Kinase Inhibitor
Download Full-text
A comparison of Janus kinase inhibitor safety in rheumatoid arthritis
International Journal of Rheumatic Diseases
◽
10.1111/1756-185x.14127
◽
2021
◽
Vol 24
(S1)
◽
pp. 3-14
Author(s):
Peter Nash
◽
Irwin Lim
◽
Mona Marabani
Keyword(s):
Rheumatoid Arthritis
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Janus Kinase Inhibitor
Download Full-text
Remission of anti‐tumor necrosis factor‐α antibody‐induced palmoplantar pustulosis with the Janus kinase inhibitor baricitinib in a patient with rheumatoid arthritis
The Journal of Dermatology
◽
10.1111/1346-8138.15860
◽
2021
◽
Author(s):
Shinichi Imafuku
◽
Akira Maeyama
Keyword(s):
Rheumatoid Arthritis
◽
Tumor Necrosis Factor
◽
Tumor Necrosis
◽
Tumor Necrosis Factor Α
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Palmoplantar Pustulosis
◽
Janus Kinase Inhibitor
◽
Factor Α
◽
Necrosis Factor
Download Full-text
OP0202 Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: opal beyond, a randomised, double-blind, placebo-controlled, phase 3 trial
10.1136/annrheumdis-2017-eular.2443
◽
2017
◽
Cited By ~ 3
Author(s):
DD Gladman
◽
WFC Rigby
◽
VF Azevedo
◽
F Behrens
◽
R Blanco
◽
...
Keyword(s):
Tumour Necrosis
◽
Kinase Inhibitor
◽
Janus Kinase
◽
Inadequate Response
◽
Efficacy And Safety
◽
Phase 3
◽
Double Blind
◽
Janus Kinase Inhibitor
◽
Double Blind Placebo
◽
Necrosis Factor
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close